Crestwood Advisors Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$62.5M Buy
255,496
+18,645
+8% +$4.34M 1.05% 24
2025
Q4
$49M Sell
236,851
-8,087
-3% -$1.6M 0.82% 35
2025
Q3
$45.4M Sell
244,938
-1,621
-0.7% -$278K 0.77% 38
2025
Q2
$37.7M Sell
246,559
-131,499
-35% -$20.2M 0.67% 48
2025
Q1
$62.7M Sell
378,058
-6,367
-2% -$996K 1.19% 24
2024
Q4
$55.6M Sell
384,425
-7,517
-2% -$1.16M 1.04% 30
2024
Q3
$63.5M Buy
391,942
+3,701
+1% +$590K 1.21% 25
2024
Q2
$56.7M Sell
388,241
-922
-0.2% -$137K 1.17% 28
2024
Q1
$61.6M Buy
389,163
+2,008
+0.5% +$320K 1.34% 25
2023
Q4
$60.7M Sell
387,155
-19,281
-5% -$2.96M 1.41% 21
2023
Q3
$63.3M Sell
406,436
-32,720
-7% -$5.4M 1.66% 19
2023
Q2
$72.7M Sell
439,156
-15,828
-3% -$2.55M 2.28% 10
2023
Q1
$70.5M Sell
454,984
-13,944
-3% -$2.25M 2.35% 6
2022
Q4
$82.8M Sell
468,928
-440
-0.1% -$76K 2.82% 3
2022
Q3
$76.7M Buy
469,368
+10,195
+2% +$1.73M 2.72% 3
2022
Q2
$81.5M Buy
459,173
+49,696
+12% +$8.85M 2.74% 4
2022
Q1
$72.6M Sell
409,477
-878
-0.2% -$149K 2.04% 11
2021
Q4
$70.2M Sell
410,355
-10,621
-3% -$1.74M 1.82% 12
2021
Q3
$68M Buy
420,976
+3,346
+0.8% +$571K 1.93% 11
2021
Q2
$68.8M Buy
417,630
+248
+0.1% +$41.1K 1.99% 9
2021
Q1
$68.6M Buy
417,382
+4,772
+1% +$772K 2.16% 8
2020
Q4
$64.9M Buy
412,610
+21,020
+5% +$3.1M 2.14% 7
2020
Q3
$58.3M Buy
391,590
+1,066
+0.3% +$158K 2.19% 6
2020
Q2
$54.9M Buy
390,524
+30,728
+9% +$4.48M 2.2% 7
2020
Q1
$47.2M Buy
359,796
+975
+0.3% +$138K 2.34% 7
2019
Q4
$52.3M Sell
358,821
-19
-0% -$2.58K 2.07% 8
2019
Q3
$46.4M Buy
358,840
+3,677
+1% +$484K 2.04% 7
2019
Q2
$49.5M Buy
355,163
+136,457
+62% +$18.9M 2.24% 6
2019
Q1
$30.6M Sell
218,706
-3,378
-2% -$452K 2.19% 13
2018
Q4
$28.7M Buy
222,084
+3,973
+2% +$554K 2.28% 11
2018
Q3
$30.1M Sell
218,111
-871
-0.4% -$116K 2.12% 13
2018
Q2
$28.5M Buy
218,982
+543
+0.2% +$67.7K 2.08% 12
2018
Q1
$28M Buy
218,439
+3,567
+2% +$482K 2.19% 11
2017
Q4
$30M Buy
214,872
+1,766
+0.8% +$246K 2.39% 7
2017
Q3
$27.7M Buy
213,106
+1,433
+0.7% +$190K 2.38% 7
2017
Q2
$27.9M Sell
211,673
-3,606
-2% -$460K 2.38% 7
2017
Q1
$26.6M Buy
215,279
+10,243
+5% +$1.22M 2.35% 7
2016
Q4
$23.6M Buy
205,036
+1,160
+0.6% +$134K 2.29% 9
2016
Q3
$24.1M Sell
203,876
-2,364
-1% -$287K 2.88% 6
2016
Q2
$25M Sell
206,240
-1,187
-0.6% -$135K 3.09% 5
2016
Q1
$22.4M Buy
207,427
+3,222
+2% +$334K 2.65% 7
2015
Q4
$21M Sell
204,205
-2,868
-1% -$288K 2.53% 7
2015
Q3
$19.3M Buy
207,073
+6,537
+3% +$632K 2.51% 8
2015
Q2
$19.5M Buy
200,536
+18,769
+10% +$1.88M 2.6% 6
2015
Q1
$18.3M Buy
181,767
+9,071
+5% +$922K 2.61% 9
2014
Q4
$18.1M Buy
172,696
+2,537
+1% +$267K 2.72% 8
2014
Q3
$18.1M Buy
170,159
+1,076
+0.6% +$112K 2.84% 7
2014
Q2
$17.7M Sell
169,083
-842
-0.5% -$85.1K 2.82% 9
2014
Q1
$16.7M Buy
169,925
+10,697
+7% +$992K 2.73% 9
2013
Q4
$14.6M Buy
159,228
+701
+0.4% +$64.6K 2.33% 13
2013
Q3
$13.7M Sell
158,527
-3,423
-2% -$307K 2.41% 10
2013
Q2
$13.9M Buy
+161,950
New +$13.7M 2.57% 9

Other funds holding JNJ

Crestwood Advisors Group's JNJ Position: Q1 2026 in Review

Crestwood Advisors Group increased its Johnson & Johnson (JNJ) stake by 7.9% in Q1 2026, buying an estimated $4.34M and bringing the position to 255,496 shares worth $62.5M. The position accounts for 1.05% of the portfolio, ranked #24.

Crestwood Advisors Group first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $82.8M in Q4 2022. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Crestwood Advisors Group held 255,496 shares of Johnson & Johnson worth $62.5M as of Q1 2026.
  • Crestwood Advisors Group bought 18,645 Johnson & Johnson shares in Q1 2026, an estimated $4.34M.
  • Johnson & Johnson made up 1.05% of Crestwood Advisors Group's portfolio in Q1 2026, its #24 holding.
  • Crestwood Advisors Group first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Crestwood Advisors Group's Johnson & Johnson position peaked at $82.8M in Q4 2022.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Crestwood Advisors Group's 13F filing for Q1 2026, filed 5 May 2026.